Engineering Healthtech and Clinical Trial Hub: Opportunities for Hong Kong

Our Hong Kong Foundation is pleased to present an Insight Forum featuring Professor Izhak Haviv, Chief Scientific Officer of AID Genomics. Global economies aspire to attract pharmaceutical corporates and unicorn novel companies to execute their growth strategies locally, engaging local academies, healthcare systems, and personnel. Drawn from his broad and thorough research and experience, Professor Haviv will share his engineer's view on research performance and identify a list of limiting parameters along with aspects of local investments that boost national performance, as well as their implications and opportunities when applying these elements into Hong Kong's landscape.